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ARTICLE
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Abstract
Major depressive disorder (MDD) is associated to affected brain wiring. Little is known whether these changes are stable
over time and hence might represent a biological predisposition, or whether these are state markers of current disease
severity and recovery after a depressive episode. Human white matter network (“connectome”) analysis via network science
is a suitable tool to investigate the association between affected brain connectivity and MDD. This study examines structural
connectome topology in 464 MDD patients (mean age: 36.6 years) and 432 healthy controls (35.6 years). MDD patients
were stratified categorially by current disease status (acute vs. partial remission vs. full remission) based on DSM-IV criteria.
Current symptom severity was assessed continuously via the Hamilton Depression Rating Scale (HAMD). Connectome
matrices were created via a combination of T1-weighted magnetic resonance imaging (MRI) and tractography methods
based on diffusion-weighted imaging. Global tract-based metrics were not found to show significant differences between
disease status groups, suggesting conserved global brain connectivity in MDD. In contrast, reduced global fractional
anisotropy (FA) was observed specifically in acute depressed patients compared to fully remitted patients and healthy
controls. Within the MDD patients, FA in a subnetwork including frontal, temporal, insular, and parietal nodes was
negatively associated with HAMD, an effect remaining when correcting for lifetime disease severity. Therefore, our findings
provide new evidence of MDD to be associated with structural, yet dynamic, state-dependent connectome alterations, which
covary with current disease severity and remission status after a depressive episode.
Introduction
Major depressive disorder (MDD) is associated with
widespread brain network dysfunction. “Disconnection
syndrome”, a term originally coined for schizophrenia
[1, 2], has become an emerging concept in MDD [3].
Investigating anatomical connectivity in patients via
neuroimaging methods relies on techniques such as diffusion
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magnetic resonance imaging (dMRI). White matter fiber
tracts can be analyzed based on their microstructural prop-
erties, which can be of use to infer on the integrity of these
tracts [4]. Furthermore, network analysis of human brain
connectivity has emerged as an effective tool to analyze the
human brain’s anatomical network organization [5]. Here,
gray matter T1-weighted magnetic resonance imaging (MRI)
was used to define nodes and dMRI-based tractography to
define the connections—or edges—between the nodes
creating a structural connectome [6]. Based on the resulting
connectivity matrix, graph theory allows for the investiga-
tion of global metrics like connectivity strength, shortest
path length, efficiency and small-worldedness [7, 8].
Previous graph theory-based connectome analyses in MDD
patients employed a variety of analysis strategies and revealed
various results: Most studies could not detect differences in
global metrices between MDD and HC [9–13]. However,
some found reduced structural connectivity in diverse sub-
networks [12, 14, 15]. Investigations of white matter micro-
structure in voxel-based dMRI studies revealed that fractional
anisotropy (FA), a dMRI-based marker of white matter
structural integrity, is reduced in several white matter tracts in
MDD patients [16]. However, it remains unclear whether
these alterations reflect current disease severity or rather a
stable risk factor in MDD patients as no studies included
remitted patients. A meta-analysis suggested reduced fiber
integrity in MDD patients with higher illness duration and
higher current disease severity without being able to disen-
tangle these factors [17]. Recently, a first longitudinal study
suggested possible recovery effects of white matter integrity 2
years after a depressive episode in MDD patients [18].
To summarize, while some studies employed connectome-
based analysis strategies on MRI data in MDD patients in recent
years, sample sizes are mostly small (all n< 100 patients) and
studies comprising patients in differing disease stages are lack-
ing, raising the question of state vs. trait alterations of the
detected connectome aberrations. This study investigates (1)
whether alterations in global network organization is preserved
in patients in a well-powered sample (2) whether instead current
disease state is associated with measures of connectome analysis
in MDD patients (3) whether changes relate more to lifetime
disease severity or the current level of depressive symptoms. We
hypothesize that while global network organization is not par-
ticularly affected in MDD, reduced FA in MDD may be indi-
cative of depressed state and current disease severity.
Methods and materials
Participants
Subjects were part of the Marburg-Münster Affective Dis-
orders Cohort Study (MACS) [19] and were recruited at two
sites (Marburg & Muenster, Germany; see ref. [20] for the
quality assurance protocol and [19] for a general descrip-
tion). In total, n= 920 participants were available (Mar-
burg: 295 MDD, 270 HC; Münster: 181 MDD, 174 HC).
Participants were recruited through newspaper advertise-
ments and local psychiatric hospitals. All experiments were
performed in accordance with the ethical guidelines and
regulations and all participants gave written informed con-
sent prior to examination. To confirm the psychiatric diag-
nosis or a lack thereof, the Structural Clinical Interview for
Diagnostic and Statistical Manual of Mental Disorders-IV-
Text Revision (DSM-IV-TR) (SCID-I; [21]) was used.
MDD subjects were included with current acute depressive
episodes (MDD-AD) and partial (MDD-PR) or full remis-
sion (MDD-FR) from depression and furthermore, patients
could be undergoing in-patient, out-patient, or no current
treatment at all. Remission status was determined based on
DSM-IV criteria (For more information on this see Sup-
plementary Material 1). Neither the groups (HC vs. MDD)
nor the MDD subgroups (MDD-AD, MDD-PR, MDD-FR)
differed in composition regarding age and sex (see Table 1).
Participants ranging in age from 18 to 65 years were
recruited. For exclusion criteria please see Supplementary
Material 2. For information on patients’ comorbidities and
medication see Supplementary Material 3.
MRI data acquisition
In the MACS Study, two MR scanners were used for data
acquisition located at the Departments of Psychiatry at the
University of Marburg and the University of Münster with
different hardware and software configurations (for MRI
data acquisition details see Supplementary Material 4). For
further details regarding MRI parameters at each site please
see our previous work [20]. Therefore, site was included as
a co-variate in all models. For more details on the site co-
variate, scanner-related investigations, co-variate analyses,
and visualization of connectome reconstructions are pro-
vided in Supplementary Material 5.
Anatomical connectome reconstruction
Connectome reconstruction involved the following steps
[8]. For each subject an anatomical brain network was
reconstructed, consisting of 114 areas of a subdivision of
the FreeSurfer’s Desikan–Killiany atlas [22, 23], and the
reconstructed streamlines between these areas. White matter
connections were reconstructed using deterministic
streamline tractography, based on the Fiber Assignment by
Continuous Tracking (FACT) algorithm [24]. We chose for
the a basic Diffusion Tensor Imaging (DTI) reconstruction
in our case–control study rather than more advanced dif-
fusion direction reconstruction methods to provide a
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reasonable balance between false-negative and false-
positive fiber reconstructions [25]. We verified our results
using higher and lower resolution parcellation of the cortex
[23] (Supplementary Material 6). Network connections
were included when two nodes (i.e., brain regions) were
connected by at least three tractography streamlines [26].
For comparable results in analyses with different thresholds
(none, 10) of tractography streamlines see Supplementary
Material 6. For each participant, the network information
was stored in a structural connectivity matrix, with rows and
columns reflecting cortical brain regions, and matrix entries
representing the weights of the graph edges. Network edges
were weighted according to fractional anisotropy (FA),
number of streamlines (NOS), and streamline density (SD)
computed as the number of streamlines between two
regions divided by their average volume.











Gender ♀143♂84 ♀83♂44 ♀74♂36 ♀268♂164 0.733b
Age, years 36.53 ± 13.44 36.71 ± 13.45 36.56 ± 13.21 35.58 ± 12.99 0.385c
Verbal IQMWTB 111.68 ± 14.31 113.05 ± 13.65 114.77 ± 13.86 114.51 ± 13.88 0.546
c
Questionnaires
HAMD 14.93 ± 6.75 7.88 ± 6.08 2.96 ± 3.30 1.54 ± 2.20 <0.0001c
Clinical
Depressive episodes 4.75 ± 6.21 4.64 ± 5.80 3.37 ± 7.117 – 0.631c
Age of onset 25.70 ± 12.50 25.85 ± 12.26 23.45 ± 10.26 – 0.029c
Medication
Medication load 1.72 ± 1.53 1.29 ± 1.25 0.51 ± 0.97 – 0.004c
CPZ 36.90 ± 114.93 13.24 ± 47.44 4.76 ± 25.31 – 0.043c
Global measures
PE 736 ± 65 740 ± 65 737 ± 55 737 ± 62 0.920c
GE 0.884 ± 0.013 0.885 ± 0.013 0.884 ± 0.012 0.883 ± 0.012 0.834c
C 3.600 ± .423 3.593 ± .402 3.609 ± .376 3.624 ± .390 0.915c
SW 2.987 ± .306 2.983 ± 0.294 2.989 ± 0.271 3.001 ± 0.285 0.899c
S 63725 ± 13762 64268 ± 14724 64848 ± 12888 64709 ± 13448 0.589c
NOS 850.82 ± 120.62 850.99 ± 13.50 87.42 ± 12.26 87.19 ± 12.72 0.376c
SD 0.0204 ± 0.0031 0.0206 ± 0.0034 0.0202 ± 0.0027 0.0201 ± 0.0029 0.745c
FA 0.378 ± 0.017 0.378 ± 0.015 0.382 ± 0.017 0.381 ± 0.016 0.028c
Hub measures
NOS of RC connections 114.796 ± 30.940 120.131 ± 37.398 115.967 ± 31.132 118.888 ± 33.533 0.320c
NOS of feeder connections 76.780 ± 13.395 76.352 ± 13.118 78.266 ± 12.796 77.460 ± 12.819 0.834c
NOS of local connections 87.920 ± 14.230 87.796 ± 14.735 89.709 ± 14.183 89.393 ± 14.353 0.266c
SD of RC connections 0.0271 ± 0.0085 0.0287 ± 0.0102 0.0267 ± 0.0080 0.0272 ± 0.0086 0.442c
SD of feeder connections 0.0182 ± 0.0031 0.0183 ± 0.0032 0.0181 ± 0.0029 0.0178 ± 0.0028 0.388c
SD of local connections 0.0209 ± 0.0034 0.0210 ± 0.0034 0.0207 ± 0.0029 0.0207 ± 0.0034 0.976c
FA of RC connections 0.436 ± 0.025 0.434 ± 0.024 0.439 ± 0.025 0.440 ± 0.024 0.078c
FA of feeder connections 0.407 ± 0.017 0.410 ± 0.017 0.411 ± 0.020 0.411 ± 0.018 0.067c
FA of local connections 0.352 ± 0.018 0.351 ± 0.017 0.356 ± 0.017 0.355 ± 0.017 0.027c
MDD-AD group with current depressive episodes, MDD-PR group with partial remission from depression, MDD-FR group with full remission
from depression, HC healthy control group, HAMD Hamilton sum score based on 21 items, CPZ chlorpromazine equivalent doses, PE present
edges (based on a binary graph), L normalized shortest path length, GE normalized global efficiency, C normalized clustering coefficient, SW
Small-worldness, S strength (total number of streamlines (i.e., sum of all streamlines)), NOS average number of streamlines per present edge,
SD average streamline density per present edge, FA average fractional anisotropy per present edge, RC Rich-Club
aNumbers present either absolute numbers or mean plus standard deviation
bχ2-test (two-tailed)
cF-test (two-tailed)
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Anatomical connectome topology
The topological organization of the anatomical brain networks
was assessed using a selection of graph metrics [27]. As an
unweighted network edge description we used the total
number of present edges (PE), based on a binarized (con-
nection present vs. connection not present) connectivity
matrix. Global efficiency (GE) was defined as the average
inverse shortest path length between all node pairs, commonly
interpreted as a metric of overall communication capacity.
Clustering coefficient (C) was computed as the average
likelihood that the neighbors of a node are also mutually
connected, as a measure of operational segregation. GE and C
were normalized in order to account for different numbers of
present edges and only normalized measures were used in the
analysis. To this end, 1000 random networks were generated
from each subject’s connectome matrix and the normalized
measures were computed as the ratio of the measure and the
average measure of the random networks. The Small-world
index (SW) was defined as the ratio of the normalized clus-
tering coefficient and the normalized shortest path length. To
compare edge weights globally between different groups, for
each subject the weights (e.g., global FA, NOS, SD) were
averaged over all edges being present in that subject. Overall
connectivity strength (S) was computed as the total sum of the
number of streamlines of all connections in the network of a
given subject.
Rich-Club (RC) organization of complex networks
expresses the tendency of high-degree nodes (the degree of a
node is the number of connections of this node) to be more
strongly interconnected than is to be expected based on their
high-degree alone [28]. RC regions—i.e., brain hubs—were
defined for each subject individually as the top 15% high-
degree nodes (see Supplementary Material 7 for repeated
analyses with different thresholds and a different hub defini-
tion). Based on the categorization of network nodes into RC
(i.e., hub) and non-RC nodes, network edges were classified
into three categories: RC connections (edges connecting
hub nodes), feeder connections (edges connecting hub to non-
hub nodes), and local connections (edges connecting non-hub
nodes). RC, feeder, and local weighted connectivity was
computed as the sum of the weights of each edge class.
Quality control
Quality control led to the exclusion of two MDD and three
HC in the Marburg sample and to the exclusion of three
MDD in the Muenster sample (Details shown in Supple-
mentary Material 8). This resulted in a final sample of 291
MDD patients (145 MDD-AD, 91 MDD-PR, and 55 MDD-
FR) and 262 HC in Marburg and 173 MDD patients (82
MDD-AD, 36 MDD-PR, 55 MDD-FR) and 170 HC in
Muenster (total n= 896).
Statistical analysis
Group differences based on remission status
An analysis of covariance (ANCOVA) was used to examine
group differences in metrics of brain network topology,
accounting for effects of age, sex and site. In total, group
status (four groups based on remission status: MDD-AD,
MDD-PR, MDD-FR, HC), sex and scanner-site entered into
the model as fixed effects terms and age as a co-variate.
Clinical correlates
To check whether possible group differences between MDD
subgroups (based on the categorical approach of remission
status) are related to current disease severity, we employed a
second approach with current depression severity scores as
a continuous variable. To this end, connectome metrics
showing significant group effects were further examined for
an association with current depression severity scores in the
MDD subsample. Acute depression severity was measured
based on the Hamilton Depression Rating Scale (HAMD)
[29]. An ANCOVA was performed with global FA as the
dependent variable, sex, site as fixed term effects and
HAMD and age as covariates.
We repeated this analysis by separately including further
clinical variables that might potentially be related to the
HAMD-FA association into the above mentioned
ANCOVA model:
(1) Number of depressive episodes; (2) Age of onset; (3)
DSM-IV diagnosis of dysthymia; (4) Medication Load
Index. For assessing the medication load, we computed an
established Medication Load Index [30–32], a composite
measure of total medication load reflecting dose and number
of prescriptions irrespective of active components. We
further examined (5) Level of childhood maltreatment
measured with the Childhood Trauma Questionnaire (CTQ,
for more information see Supplementary Material 9) and (6)
Polygenetic Risk Score (PRS) for Major Depressive Dis-
order based on a recent Genome-wide association study
(GWAS) analysis (see Supplementary Material 9).
Network-based-statistics
To further explore which brain connections are related to
the global FA reduction associated with an increased
HAMD score within the MDD subsample, we used
network-based statistics (NBS) [33] to detect the set of
connections related to HAMD. NBS identifies an effect at
cluster level by performing mass univariate testing at the
edge level controlled for family-wise error (FWE). First,
each edge was assigned a t-value obtained from a negative
association between FA value und HAMD score while
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correcting for age, sex and scanner-site. The test statistic
computed for each pairwise association was thresholded to
select all supra-threshold links. Next, the largest component
of supra-threshold connections was selected to detect the
strongest set of HAMD-related connections. Permutation
testing (randomizing HAMD scores) using 5000 permuta-
tions was performed to ascribe a p-value controlled for
FWE to the cluster of HAMD-related edges based on
component size. For this analysis, we report and illustrate
the component size of significant results based on different
t-thresholds in Supplementary Material 10. To illustrate the
most affected edges we report on a cluster with a supra-
threshold t-value of t= 2.0 [33]. Further analyses with more
lenient t-thresholds and a larger cluster size are presented in
Supplementary Material 11.
Results
Comparison of groups dependent on remission
status
Acute depressed, partially remitted, fully remitted MDD
patients (MDD-AD, MDD-PR, MDD-FR) and HC did not
differ regarding age (p= 0.726) and sex (p= 0.734). For
details see Table 1. MDD subgroups differed in clinical
characteristics, with a lower age of onset, higher Medication
Load Index and higher prevalence of dysthymia in the
MDD-AD group compared to the MDD-FR group
(Table 1). Other comorbidities were comparable across
MDD subgroups (see Supplementary Material 3).
We found no evidence that groups differed regarding
PE (p= 0.920), GE (p= 0.834), C (p= 0.915), SW (p=
0.899), S (p= 0.589), NOS (p= 0.376), and SD
(p= 0.745). We observed a main effect of group
(F(3889)= 3.124, p= 0.025, η²= 0.010) for FA (see
Table 1 for details). Post-hoc t-test revealed reduced FA
in MDD-AD compared to MDD-FR (p= 0.015,
η²= .021) and HC (p= 0.034, η²= 0.007). The same
pattern was found for MDD-PR, who showed reduced FA
compared to MDD-FR (p= 0.028, η²= 0.018). See Fig. 1
for details. Results remained consistent across different
connectome preprocessing strategies (i.e., for different
node parcellations and different minimum number of
streamlines please, see Supplementary Material 6 for
further details, and for different hub definitions, see
Supplementary Material 7).
NOS and SD did not differ across groups in Rich-Club,
Feeder or Local connections (all p > 0.26). Regarding FA,
there was no effect of group in rich club (p= 0.078) and
feeder connections (p= 0.067). The class of local connec-
tions showed a main effect of group (F(3888)= 3.186 p=
0.023). Post-hoc t-tests revealed significantly higher FA in
local connections MDD-FR patients compared to MDD-PR
(p= 0.010) and to MDD-AD (p= 0.014).
Association with current depression severity
Based on the finding of reduced global FA in MDD-AD and
MDD-PR we then tested whether FA values were asso-
ciated with current depression severity (by means of HAMD
score) in MDD patients. Analysis revealed a negative
association of global FA with HAMD (F(1457)= 9.337,
p= 0.002, η²= 0.020) in an ANCOVA correcting for age,
sex, and site. For a scatterplot depicting the HAMD-FA
relationship color-coded by remission status please see
Supplementary Material 12. Subanalyses analyzing rich
club/feeder/local connections revealed no further associa-
tion of rich club FA with HAMD (p= 0.208). FA of feeder
connections was significantly negatively associated with
HAMD (F(1457)= 9.016, p= .003, η²= 0.019). FA of
local connections also showed a significant negative asso-
ciation with HAMD (F(1457)= 8.513, p= 0.004, η²=
0.018). For analysis of normality, heterogeneity and corre-
sponding non-linear models see Supplementary Material 13;
for power analysis see Supplementary Material 14.
Additional analyses correcting for clinical covariates,
childhood maltreatment and genetic risk
ANCOVA analyses revealed a stable global FA—HAMD
association even when additionally correcting for number of
Fig. 1 Raincloud plot [51] of global fractional anisotropy (FA) values.
FA values were the mean of all edges. A main effect of group was
detected in an ANCOVA correcting for age, sex, and site. Asterisk
represents statistical significance (p < 0.05) in post-hoc-t-tests. Values
are reported for all subgroups: Acute depressed, partially remitted,
fully remitted MDD patients (MDD-AD, MDD-PR, MDD-FR; based
on DSM-V criteria) and healthy controls (HC). The boxplots display
respective sample median alongside interquartile range. The mean
value within each group is displayed as a blue dot
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depressive episodes (HAMD: F(1416)= 1.568, p= 0.013,
η²= 0.015); diagnosis of dysthymia (HAMD: F(1456)=
9.095, p= 0.003, η²= 0.020) and Medication Load Index
(HAMD: F(1456)= 5.453, p= 0.003, η²= 0.020; for
additional medication analyses see Supplementary Mate-
rial 15). Correcting for age of onset similarly revealed a
stable global FA—HAMD association (F(1457)= 9,337,
p= 0.002, η²= .020). Moreover, adding childhood
maltreatment (HAMD: F(1442)= 5.165, p= 0.024,
η²= 0.012) or polygenetic risk for depression (HAMD:
F(1206)= 4931, p= 0.027, η²= 0.023) to the model did
not alter the observed pattern of results.
NBS analysis
NBS analysis showed a negative association of FA and
HAMD in a subnetwork consisting of 94 edges (see Fig. 2
and Supplementary Material 10) at a corrected significance
level of p(FWE) < 0.001 (NBS t-threshold 2.0). This subnet-
work comprised a widespread network, including (orbito-)
frontal, temporal, cingulate, parietal, and insular nodes
(regions listed in Supplementary Material 10, see also
Supplementary Material 11 for additional analysis with a
more lenient t-threshold).
Discussion
This study investigated the association of depression status
on white matter structure in a sample of depressed and
remitted MDD patients. This study contributes to the
important question of whether observed connectome
alterations are rather a trait or state correlate of MDD. We
show that while the general edge topology seems unaffected
in MDD patients, effects are observed in connectivity
strength (FA) per se, especially depending on current dis-
ease severity.
We did not detect any group differences regarding global
network features. This finding is in line with several pre-
vious studies with smaller sample sizes showing no differ-
ences in global metrics like number of present edges,
connectivity strength, global efficiency or small-worldness
[9, 10]. Also, comparable to the finding of unimpaired
global network properties based on streamlines and present
edges, no aberrations in subnetworks are found based on
hub organization. [30, 34].
Instead, our findings show that MDD is associated
with more centralized affected integrity of white matter
microstructure of fronto-temporal tracts, and in parti-
cular in acute depression. Our results show significantly
lower FA in acute depressed vs. fully remitted MDD
patients. Additional ANCOVA with a continuous
depression score further revealed a negative relationship
of HAMD scores and global FA in all patients. NBS
analysis further showed that this negative association of
HAMD with FA may potentially be mostly driven by a
subnetwork including among others orbitofrontal, insular
parietal and temporal connections (Fig. 2). This network
comprises brain nodes generally implicated in MDD
pathophysiology [35] and future studies should investi-
gate whether reduced FA in this network in acute
depression serves as an anatomical substrate for known
Fig. 2 Edges (red) and nodes
(blue) that show a negative
association of current depression
severity (Hamilton Depression
Score) and fractional anisotropy
(FA) within the major
depressive disorder patient
sample. Results show a
subnetwork based on a network-
based-statistics analysis with a
p-value (FWE-corrected) of p <
0.001 and a supra-threshold
t-value of t= 2.0. Images were
created using the BrainNet
Viewer software [52]. a axial
view. b sagittal view.
c Scatterplot depicting the
association of mean FA
(extracted from the significant
cluster) and Hamilton
Depression Score
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functional connectivity impairments in MDD within
these regions [36].
Disentangling possible influences of current depression
severity and lifetime disease severity (age of onset, number
of depressive episodes, medication) remains challenging.
Further controlling for potential covariates such as age of
onset, medication, dysthymia, childhood maltreatment or
the polygenetic risk for depression in the ANCOVA did not
change the pattern of our findings, supporting the concept of
a robust association of acute depression severity with white
matter microstructure. Fully remitted patients showed sig-
nificantly better white matter microstructure than acute
depressed patients and with no specific difference to healthy
controls. Although care is needed due to the cross-sectional
design of the study, numerical FA values in fully remitted
MDD patients suggest a level of recovery compared to non-
remitted patients.
Our study is cross-sectional in nature, but our findings
are in line with the few longitudinal DTI studies in MDD
that reported signs of recovery of white matter micro-
structure disturbances [37]. Furthermore, they are in support
of potential slowing of the rate of white matter degradation
during the disease course [38]. While underlying cellular
mechanisms remain to be understood, evidence suggests
that stress-related and immunological changes might med-
iate the association of depression state and white matter
microstructure integrity in MDD [39–42].
The question of whether these observed changes are
specific to MDD or whether they reflect overlapping themes
of white matter alterations, similar to changes observed in
other psychiatric disorders needs to be investigated in direct
cross-diagnostic studies. Comparing previous work in
schizophrenia (SZ) [7, 43] and bipolar disorder (BP) [44]
with our results do suggest differences in connectome
aberrations. While SZ patients have been suggested to show
reduction of white matter connectivity and global changes
in network topology [45], we could not detect strong effects
in global network organization in our MDD patients, which
suggests a relative preserved general connectome topology
in MDD. FA analysis on rich-club, feeder and local con-
nections further revealed similar levels of impairment in
MDD, with no specific emphasis on hub connectivity [46].
Future large-scale structural connectome studies focusing
on the remission status of psychiatric disorders in relation-
ship to white matter organization [47] are of general
interest.
Several methodological points have to be taken into
consideration when interpreting the findings of this study.
FA as a marker of white matter microstructure is related to
many different types of tissue change (e.g., membrane
permeability, crossing of fibers), which makes interpretation
about the neurobiological meaning of DTI metrics chal-
lenging [48]. However, FA has proven useful in the past as
a marker of pathological effects in MDD [16, 30] and has
shown relevance in its positive association to several cog-
nitive domains [49]. Second, statements about remission
and recovery need to be treated with caution, as this study is
cross-sectional. However, there are no differences in most
demographic and clinical characteristics in the MDD sub-
groups. Adding characteristics that did display significant
differences between the MDD subgroups (medication,
dysthymia, etc.), into the regression models did not alter the
observed results. Moreover, as current disease severity and
remission status are related, disentangling separate effects
of those two concepts within a cross-sectional study is
challenging. Future longitudinal studies are needed to fur-
ther support the observed effects of both remission status
and current disease severity on FA. Third, addressing the
influence of medication, especially lifetime medication
load, on brain structure is challenging in a cross-sectional
design. However, analyses with current medication load did
not reveal any specific association with white matter
microstructure in this sample. Fourth, it is important to
mention that the observed effects of FA were small, making
it unlikely for structural connectome investigations in the
future to uncover a sole neurobiological substrate for the
multidimensional etiology of the relapsing-remitting pattern
of MDD. Although small in effect size (comparable to other
genetic and brain imaging studies in psychiatric disorders
[50]), our results do present important new evidence for a
possible dynamic role of white matter structural con-
nectivity in MDD remission. Finally, we cannot exclude the
possibility of having missed even smaller effects in the
other global metrics (GE, C, SW, etc.). However, power
analyses revealed sufficient power to detect relevant effects
for global connectome metrics.
Our findings show that connectome alterations, specifi-
cally impairment of white matter microstructure in a large
subnetwork comprising frontal, temporal, insular, and par-
ietal nodes are associated with current depression severity in
MDD. Our results suggest possible recovery of white matter
microstructure after an acute depressive episode.
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